San Francisco, CA, United States of America

Zhenping Tian

This inventor holds 1 USPTO granted patent. Top assignee: Abbvie Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhenping Tian. Retrieved from https://idiyas.com/inventor/zhenping-tian-6ra68o74

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhenping Tian: Innovator in Pharmaceutical Chemistry

Introduction

Zhenping Tian is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target histamine receptors.

Latest Patents

Zhenping Tian holds a patent for "Cyclopropyl amine derivatives." This patent includes compounds of formula (I), wherein R, R, R, R, R, R, and R are defined in the description. These compounds are useful in treating conditions or disorders that can be prevented by or ameliorated by histamine-3 receptor ligands. The patent also discloses pharmaceutical compositions that comprise these ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

Career Highlights

Zhenping Tian is currently employed at AbbVie Inc., a leading global biopharmaceutical company. His work focuses on innovative solutions in drug development, particularly in the area of histamine receptor modulation.

Collaborations

Some of his notable coworkers include Huaqing Liu and Lawrence A. Black. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical sector.

Conclusion

Zhenping Tian's work exemplifies the impact of innovative research in the pharmaceutical industry. His contributions, particularly in the area of histamine-3 receptor ligands, highlight the importance of continued innovation in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…